Table 2.
Provider practice styles according to average treatment intensity
| Processes of care | Quartiles of provider treatment intensity |
P* | |||
| 1 (low) | 2 | 3 | 4 (high) | ||
| Surveillance related | |||||
| Endoscopic surveillance, mean number of procedures | 7.3 | 7.7 | 7.9 | 8.3 | <.001 |
| Upper urinary tract evaluation, mean number of tests | 0.9 | 1.0 | 1.0 | 1.2 | <.001 |
| Radiographic imaging, mean number of studies | 5.1 | 5.1 | 5.4 | 6.0 | <.001 |
| Urinary cytology, mean number of tests | 1.3 | 1.7 | 1.9 | 2.3 | <.001 |
| Urine cytology, mean % of patients | 41.3 | 47.8 | 50.4 | 56.8 | <.001† |
| Urinalysis, mean number of tests | 7.3 | 7.3 | 8.4 | 8.5 | <.001 |
| Treatment related | |||||
| Intravesical therapy, mean number of instillations | 2.6 | 3.4 | 4.1 | 5.0 | <.001 |
| Induction courses‡ of intravesical therapy, mean number | 0.5 | 0.5 | 0.6 | 0.6 | <.001 |
| Induction intravesical therapy, mean % of patients | 21.7 | 25.8 | 30.2 | 36.0 | <.001† |
| Repeat endoscopic resection, mean % of patients | 4.7 | 5.6 | 6.4 | 9.6 | <.001† |
| Medical services | |||||
| Visits to the urologist, mean number | 3.4 | 3.5 | 4.1 | 4.2 | <.001 |
| Visits to the other physicians, mean number | 20.2 | 19.4 | 19.8 | 19.9 | .12 |
P values based on two-sided Kruskal–Wallis test except where indicated.
Two-sided chi-square test.
Five or more treatments of intravesical therapy within a 45-day period.